Ownership history in FEDERATED HERMES, INC. · 64 quarters on record
This page tracks every 13F SEC filing in which FEDERATED HERMES, INC. reported a position in CORCEPT THERAPEUTICS INC COM (CORT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 4,365 | -2,172 | -33.2% | 0.00% | $363K | $83.11 |
| 2025 Q2 | REDUCED | 6,537 | -6,335 | -49.2% | 0.00% | $480K | $73.40 |
| 2025 Q1 | REDUCED | 12,872 | -998 | -7.2% | 0.00% | $1.5M | $114.22 |
| 2024 Q4 | ADDED | 13,870 | +7,172 | +107.1% | 0.00% | $699K | $50.39 |
| 2024 Q3 | REDUCED | 6,698 | -32,061 | -82.7% | 0.00% | $310K | $46.28 |
| 2024 Q2 | REDUCED | 38,759 | -11,147 | -22.3% | 0.00% | $1.3M | $32.49 |
| 2024 Q1 | REDUCED | 49,906 | -1,639,823 | -97.0% | 0.00% | $1.3M | $25.19 |
| 2023 Q4 | REDUCED | 1,689,729 | -1,645 | -0.1% | 0.14% | $54.9M | $32.48 |
| 2023 Q3 | REDUCED | 1,691,374 | -1,068,922 | -38.7% | 0.12% | $46.1M | $27.25 |
| 2023 Q2 | UNCHANGED | 2,760,296 | — | 0% | 0.15% | $61.4M | $22.25 |
As of 2025 Q4 — sorted by position size